KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Raw Materials (2016 - 2020)

Historic Raw Materials for Emergent BioSolutions (EBS) over the last 11 years, with Q1 2020 value amounting to $77.7 million.

  • Emergent BioSolutions' Raw Materials changed N/A to $77.7 million in Q1 2020 from the same period last year, while for Mar 2020 it was $77.7 million, marking a year-over-year change of. This contributed to the annual value of $70.5 million for FY2019, which is 3610.04% up from last year.
  • Latest data reveals that Emergent BioSolutions reported Raw Materials of $77.7 million as of Q1 2020.
  • In the past 5 years, Emergent BioSolutions' Raw Materials ranged from a high of $77.7 million in Q1 2020 and a low of $25.7 million during Q1 2016
  • For the 5-year period, Emergent BioSolutions' Raw Materials averaged around $43.3 million, with its median value being $34.3 million (2017).
  • As far as peak fluctuations go, Emergent BioSolutions' Raw Materials plummeted by 67.5% in 2018, and later skyrocketed by 10387.06% in 2019.
  • Over the past 5 years, Emergent BioSolutions' Raw Materials (Quarter) stood at $30.7 million in 2016, then rose by 17.64% to $36.1 million in 2017, then skyrocketed by 43.49% to $51.8 million in 2018, then soared by 36.1% to $70.5 million in 2019, then increased by 10.21% to $77.7 million in 2020.
  • Its last three reported values are $77.7 million in Q1 2020, $70.5 million for Q4 2019, and $69.0 million during Q3 2019.